Yixintang Pharmaceutical Co Ltd. Stock Analysis 002727.SZ

Yixintang Pharmaceutical Group Co., Ltd. engages in the pharmaceutical retail chain and pharmaceutical wholesale business. The company is headquartered in Kunming, Yunnan and currently employs 34,848 full-time employees. The company went IPO on 2014-07-02. The firm is also engaged in major health industries such as pharmaceutical distribution, traditional Chinese medicine industry, medical business, convenience goods, personal care and beauty. The firm's main products include regular decoction pieces, direct oral decoction pieces, active ingredients, ultrafine powders, toxic decoction pieces, and formula granules. The firm mainly operates five major brands: Hongxiang, Shanshang, Huipin, Bendian and Hanzun. The firm mainly operates its businesses in the domestic market.